Your browser doesn't support javascript.
loading
Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia.
Xu, Zhangdi; Pan, Bihui; Miao, Yi; Li, Yue; Qin, Shuchao; Liang, Jinhua; Kong, Yilin; Zhang, Xinyu; Tang, Jing; Xia, Yi; Zhu, Huayuan; Wang, Li; Li, Jianyong; Wu, Jiazhu; Xu, Wei.
Afiliación
  • Xu Z; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Pan B; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Miao Y; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Li Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Qin S; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Liang J; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Kong Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Zhang X; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Tang J; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Xia Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Zhu H; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Wang L; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Wu J; Key Laboratory of Hematology of Nanjing Medical University, Nanjing, 210029, China.
  • Xu W; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
Clin Exp Med ; 23(6): 2651-2662, 2023 Oct.
Article en En | MEDLINE | ID: mdl-36738306
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Exp Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Exp Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China